Upcoming Evolent Program Enhancements for Ambetter Health Providers: Effective December 2026
Summary
Ambetter Health is implementing two program enhancements effective December 2026: (1) Beginning December 1, Evolent will issue direct denial determinations for oncology prior authorizations that don't meet clinical criteria instead of issuing Recommended Adverse Determinations; (2) Beginning December 5, Evolent will require site-of-care selection for shoulder, hip, knee, and spine surgeries with clinical justification if hospital-based settings are chosen for outpatient-eligible procedures.
Get alerts when payers change rules like this one
We check Ambetter and other payers every day and email you when a change matches your specialty and state.